The AIM-HI Accelerator Fund (AIM-HI) just announced 6 Semi-Finalists for the 2022 AIM-HI Women’s Venture Competition! These innovative oncology start-ups have been selected from an exceptional pool of applications submitted by women scientist-entrepreneurs worldwide.
The AIM-HI Women’s Venture Competition, now in its third year, provides funding, coaching, and networking opportunities to women-led oncology start-ups to address unmet medical needs. The chosen semi-finalists will advance to a Virtual Competition on May 31, 2022.
AIM-HI has an unparalleled vigorous review process to determine the most deserving winner with high patient impact. Our Selection and Judging Committees are comprised of world-class key opinion leaders, life sciences industry experts, investors, and entrepreneurs. The winner of the 2022 AIM-HI Women’s Venture Competition will receive $1 million in investment from AIM-HI and co-investors. The funding will accelerate the development of new effective cancer treatments on the path to clinical trials and, eventually, for a cure.
Hear From the Semi-Finalists:
This article originally appeared on https://aim-hiaccelerator.org/. You can support their work here, and your gifts will empower women leaders who are creating life-saving oncology innovations!